Mouse senile amyloid fibrils deposited in skeletal muscle exhibit amyloidosis-enhancing activity

PLoS Pathogens

Volumn 6, Issue 5, 2010, Pages 1-8

  Qian, Jinze ^a,b   Yan, Jingmin ^a   Ge, Fengxia ^a   Zhang, Beiru ^a   Fu, Xiaoying ^a   Tomozawa, Hiroshi ^c   Sawashita, Jinko ^a   Mori, Masayuki ^a   Higuchi, Keiichi ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c SHINSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; APOLIPOPROTEIN A2; MESSENGER RNA;

AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; INTERSTITIUM; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RISK ASSESSMENT; SKELETAL MUSCLE; AMYLOID PLAQUE; ANIMAL; GENETICS; MALE; METABOLISM; PATHOLOGY; PROTEIN DENATURATION; TRANSGENIC MOUSE; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALIA; MUS;

AMYLOID; AMYLOIDOSIS; ANIMALS; APOLIPOPROTEIN A-II; FEMALE; MALE; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCLE, SKELETAL; PLAQUE, AMYLOID; PROTEIN DENATURATION; RNA, MESSENGER;

EID: 77954054472     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000914     Document Type: Article

References (50)

1. Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, et al. (2007) A primer of amyloid nomenclature. Amyloid 14: 179-183.
2. Benson MD, James S, Scott K, Liepnieks JJ, Kluve-Beckerman B (2008) Leukocyte chemotactic factor 2: A novel renal amyloid protein. Kidney Int 74: 218-222.
3. Lundmark K, Westermark GT, Nystrom S, Murphy CL, Solomon A, et al. (2002) Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc Natl Acad Sci USA 99: 6979-6984.
4. Zhang B, Une Y, Fu X, Yan J, Ge F, et al. (2008) Fecal transmission of AA amyloidosis in the cheetah contributes to high incidence of disease. Proc Natl Acad Sci USA 105: 7263-7268.
5. Xing Y, Higuchi K (2002) Amyloid fibril proteins. Mech Ageing Dev 123: 1625-1636. Review.
6. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95: 13363-13383.
7. Collinge J (2001) Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24: 519-550.
8. Li WH, Tanimura M, Luo CC, Datta S, Chan L (1988) The apolipoprotein multigene family: biosynthesis, structurefunction relationship, and evolution. J Lipid Res 29: 245-271.
9. Chapman MJ (1986) Comparative analysis of mammalian plasma lipoproteins. Methods Enzymol 128: 70-143.
10. Xing Y, Nakamura A, Korenaga T, Guo Z, Yao J, et al. (2002) Induction of protein conformational change in mouse senile amyloidosis. J Biol Chem 277: 33164-33169.
11. Higuchi K, Kitagawa K, Naiki H, Hanada K, Hosokawa M, et al. (1991) Polymorphism of apolipoprotein A-II (apoA-II) among inbred strains of mice. Relationship between the molecular type of apoA-II and mouse senile amyloidosis. Biochem J 279: 427-433.
12. Kitagawa K, Wang J, Mastushita T, Kogishi K, Hosokawa M, et al. (2003) Polymorphism of mouse apolipoprotein A-II: seven alleles found among 41 inbred strains of mice. Amyloid 10: 207-214.
13. Higuchi K, Naiki H, Kitagawa K, Kitado H, Kogishi K, et al. (1995) Apolipoprotein A-II gene and development of amyloidosis and senescence in a congenic strain of mice carrying amyloidogenic ApoA-II. Lab Invest 72: 75-82.
14. Walker LC, Levine H, 3rd, Mattson MP, Jucker M, et al. (2006) Inducible proteopathies. Trends Neurosci 29: 438-443.
15. Higuchi K, Kogishi K, Wang J, Chen X, Chiba T, et al. (1998) Fibrilization in mouse senile amyloidosis is fibril conformation-dependent. Lab Invest 72: 1535-1542.
16. Zhang H, Sawashita J, Fu X, Korenaga T, Yan J, et al. (2006) Transmissibility of mouse AApoAII amyloid fibrils: inactivation by physical and chemical methods. FASEB J 20: 1012-1014.
17. Xing Y, Nakamura A, Chiba T, Kogishi K, Matsushita T, et al. (2001) Transmission of mouse senile amyloidosis. Lab Invest 81: 493-499.
18. Korenaga T, Yan J, Sawashita J, Matsushita T, Naiki H, et al. (2006) Transmission of amyloidosis in offspring of mice with AApoAII amyloidosis. Am J Pathol 168: 898-906.
19. Jarrett JT, Lansbury PT, Jr. (1993) Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73: 1055-1058.
20. Soto C (2003) Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci 4: 49-60.
21. Takeshita S, Hosokawa M, Irino M, Higuchi K, Shimizu K, et al. (1981) Spontaneous age-associated amyloidosis in senescence-accelerated mouse (SAM). Mech Ageing Dev 20: 13-23.
22. Peden AH, Ritchie DL, Head MW, Ironside JW (2006) Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease. Am J Pathol 168: 927-935.
23. Bosque PJ, Ryou C, Telling G, Peretz D, Legname G, et al. (2002) Prions in skeletal muscle. Proc Natl Acad Sci USA 99: 3812-3817.
24. Ge F, Yao J, Fu X, Guo Z, Yan J, et al. (2007) Amyloidosis in transgenic mice expressing murine amyloidogenic apolipoprotein A-II (Apoa2c). Lab Invest 87: 633-643.
25. Higuchi K, Hosokawa M, Taketa T (1999) Senescence-accelerated mouse. Methods Enzymol 309: 674-686.
26. Collinge J (1999) Variant Creutzfeldt-Jakob disease. Lancet 354: 317-323.
27. Thomzig A, Kratzel C, Lenz G, Kruger D, Beekes M (2003) Widespread PrPSc accumulation in muscles of hamsters orally infected with scrapie. EMBO Rep 4: 530-533.
28. Thomzig A, Schulz-Schaeffer W, Kratzel C, Mai J, Beekes M (2004) Preclinical deposition of pathological prion protein PrPSc in muscles of hamsters orally exposed to scrapie. J Clin Invest 113: 1465-1472.
29. Thomzig A, Cardone F, Kruger D, Pocchiari M, Brown P, et al. (2006) Pathological prion protein in muscles of hamsters and mice infected with rodentadapted BSE or vCJD. J Gen Virol 87: 251-254.
30. Andreoletti O, Simon S, Lacroux C, Morel N, Tabouret G, et al. (2004) PrPSc accumulation in myocytes from sheep incubating natural scrapie. Nat Med 10: 591-593.
31. Angers RC, Browning SR, Seward TS, Sigurdson CJ, Miller MW, et al. (2006) Prions in skeletal muscles of deer with chronic wasting disease. Science 311: 1117.
32. Glatzel M, Abela E, Maissen M, Aguzzi A (2003) Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 349: 1812-1820.
33. Hamir AN, Miller JM, Cutlip RC (2004) Failure to detect prion protein (PrPres) by immunohistochemistry in striated muscle tissues of animals experimentally inoculated with agents of transmissible spongiform encephalopathy. Vet Pathol 41: 78-81.
34. Cui D, Kawano H, Takahashi M, Hoshii Y, Setoguchi M, et al. (2002) Acceleration of murine AA amyloidosis by oral administration of amyloid fibrils extracted form different species. Pathol Int 52: 40-45.
35. Yamada M, Kotani Y, Nakamura K, Kobayashi Y, Horiuchi N, et al. (2006) Immunohistochemical distribution of amyloid deposits in 25 cows diagnosed with systemic AA amyloidosis. J Vet Med Sci 68: 725-729.
36. Tojo K, Tokuda T, Hoshii Y, Fu X, Higuchi K, et al. (2005) Unexpectedly high incidence of visceral AA-amyloidosis in slaughtered cattle in Japan. Amyloid 12: 103-108.
37. Yoshida T, Zhang P, Fu X, Higuchi K, Ikeda S (2009) Slaughtered aged cattle might become one dietary source exhibiting amyloid enhancing factor activity. Amyloid 16: 25-31.
38. Corinne IL, Jean-Philippe D, Olivier R, Alexandre J, Vincent B, et al. (1997) Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275: 402-405.
39. Fu X, Korenaga T, Fu L, Xing Y, Guo Z, et al. (2004) Induction of AApoAII amyloidosis by various heterogeneous amyloid fibrils. FEBS Lett 563: 179-184.
40. Fowler DM, Koulov AV, Balch WE, Kelly JW (2007) Functional amyloid-from bacteria to humans. Trends Biochem Sci 32: 217-224.
41. Münch J, Rücker E, Ständker L, Adermann K, Goffinet C, et al. (2007) Semenderived amyloid fibrils drastically enhance HIV infection. Cell 131: 1059-1071.
42. Relini A, De Stefano S, Torrassa S, Cavalleri O, Rolandi R, et al. (2008) Heparin strongly enhances the formation of beta2-microglobulin amyloid fibrils in the presence of type I collagen. J Biol Chem 283: 4912-4920.
43. Kovács GG, Kalev O, Gelpi E, Haberler C, Wanschitz J, et al. (2004) The prion protein in human neuromuscular diseases. J Pathol 204: 241-247.
44. Huang S, Liang J, Zheng M, Li X, Wang M, et al. (2007) Inducible overexpression of wild-type prion protein in the muscles leads to a primary myopathy in transgenic mice. Proc Natl Acad Sci 104: 6800-6805.
45. Zanusso G, Vattemi G, Ferrari S, Tabaton M, Pecini E, et al. (2001) Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy. Brain Pathol 11: 182-189.
46. Jayaraman M, Kannayiram G, Rajadas J (2008) Amyloid toxicity in skeletal myoblasts: Implications for inclusion-body myositis. Arch Biochem Biophys 474: 15-21.
47. Pras M, Schubert M, Zucker-Franklin D, Rimon A, Franklin EC (1968) The characterization of soluble amyloid prepared in water. J Clin Invest 47: 924-933.
48. Puchtler H, Sweat F, Levine M (1962) On the binding of Congo red by amyloid. J Histochem Cytochem 10: 355-364.
49. Higuchi K, Matsumura A, Honma A, Takeshita S, Hashimoto K, et al. (1983) Systemic senile amyloid in senescence-accelerated mice: a unique fibril protein demonstrated in tissues from various organs by the unlabeled immunoperoxidase method. Lab Invest 48: 231-240.
50. Schagger H, Jagow G (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166: 368-379.